Activirosomes is developing new, inherently safe, low cost and easy to produce vaccine agents for prevention of viral infections. We use the "Active Virosome" technology platform, developed by co-founder Dr Vishwas Joshi of Seagull Biosolutions Pvt Ltd, www.seagullbiosolutions.in. It is a simple, safe and efficient biotechnology for producing candidate vaccines, and can be easily modified to produce vaccines for new viral infection outbreaks, simply by slotting in a suitable "cassette" of genetic information.